Evaluation of a new Q-switched Nd:YAG laser on premacular hemorrhage

BMC Ophthalmol. 2023 Apr 7;23(1):146. doi: 10.1186/s12886-023-02876-7.

Abstract

Background: Premacular hemorrhage is among the causes of sudden deterioration of visual acuity. This study aimed to investigate the therapeutic outcomes of a new Q-switched Nd:YAG laser on premacular hemorrhage.

Methods: Retrospective, case series study of 16 eyes from 16 patients diagnosed with premacular hemorrhage, including 3 cases of Valsalva retinopathy, 8 cases of retinal macroaneurysm, 3 cases of diabetic retinopathy, 1 case of trauma-related hemorrhage and 1 case with leukemia. A 1064nm Q-switched Nd:YAG laser was performed to puncture the posterior hyaloid and inner limiting membrane to drain the hemorrhage.

Results: The success rate of 16 patients with premacular hemorrhage drainage was 100% in this study. Improved visual acuity was observed in each patient.

Conclusions: In this case series of 16 patients, the new Q-switched Nd:YAG laser was successful in draining premacular hemorrhage with no serious complications.

Keywords: Case series; Nd:YAG laser; Premacular hemorrhage; Q-switched laser.

MeSH terms

  • Humans
  • Laser Therapy* / adverse effects
  • Lasers, Solid-State* / therapeutic use
  • Retinal Hemorrhage / diagnosis
  • Retinal Hemorrhage / etiology
  • Retinal Hemorrhage / surgery
  • Retrospective Studies
  • Treatment Outcome
  • Vitreous Body